• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Mangalam Drugs And Organics Limited — Board Meeting, 20-11-2025: Outcome of Board Meeting

    20-11-2025 | 08:11 pm

    Mangalam Drugs announced a Q2/H1 FY26 consolidated net loss of ₹21.14 Cr, impacted by US-AID funding cuts. The company is discussing a restructuring plan with lenders. Its CFO resigned, and a merger scheme hearing is set for Dec 16. Auditors issued a modified opinion on deferred tax assets.

    No comments yet. Be the first to comment!

    All announcements from Mangalam Drugs And Organics Limited